Parnax Lab Ltd.

View in App
89.25 +1.75 ▲2.0%

04 October 2023, 04:01:00 PM
Volume: 3,949

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.naxparlab.com
Market Cap 102.51 Cr.
Enterprise Value(EV) 148.62 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 8.72 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) 10.24 Trailing Twelve Months Ending 2023-06
Industry PE 38.26 Trailing Twelve Months Ending 2023-06
Book Value / Share 57.11 Trailing Twelve Months Ending 2023-06
Price to Book Value 1.56 Calculated using Price: 89.25
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.15 Cr. 11,485,616 Shares
FaceValue 10
About Parnax Lab Ltd.
Parnax Lab, earlier known as Krishnadeep Trade and Investments, incorporated in the year 1982, engages in investing and financial businesses in India. The company is based in Mumbai, India. In 2012 the company has changed its name from Krishna Deep Trade & Investments Ltd. to Parnax Lab Ltd. "

Parnax Lab Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Parnax Lab Ltd. Performance

View details >>
1 Day
+2.00%
1 Week
+1.99%
1 Month
+6.35%
3 Month
+43.44%
6 Month
+68.65%
1 Year
+12.90%
2 Year
+259.15%
5 Year
+137.68%
10 Year
+87.11%

Parnax Lab Ltd. Fundamental Ratios

View details >>
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 12.70 18.50 9.50 12.51 3.31 9.69 -8.51 -1.11 20.93
Return on Capital Employed (%) 14.16 16.35 11.47 13.73 10.49 11.59 3.27 5.83 17.34
Return on Assets (%) 3.47 5.12 3.09 4.48 1.22 3.63 -2.89 -0.34 6.36

Parnax Lab Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 21 25 28 31 33 36 33 33 48 62
Non Curr. Liab. 22 27 23 18 18 23 22 19 24 20
Curr. Liab. 41 31 29 36 37 36 52 54 81 63
Minority Int. 0 0 0 0 0 0 0 0 0 0
Equity & Liab. 83 83 79 86 87 95 107 106 153 145
Non Curr. Assets 37 45 49 55 51 58 62 67 79 84
Curr. Assets 46 38 31 31 36 37 46 39 75 61
Misc. Exp. not W/O 0 0
Total Assets 83 83 79 86 87 95 107 106 153 145

Parnax Lab Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 69 103 71 95 106 109 95 90 163 180
Other Income 1 1 1 1 1 2 1 0 0 1
Total Income 70 104 72 96 107 111 96 90 163 181
Total Expenditure -60 -91 -61 -82 -96 -99 -89 -80 -140 -155
PBIDT 9 13 11 13 11 12 7 10 23 25
Interest -4 -4 -4 -5 -4 -4 -5 -5 -5 -5
Depreciation -2 -3 -3 -4 -4 -4 -4 -5 -6 -6
Taxation -1 -1 -1 -1 -2 -1 -1 0 -4 -4
Exceptional Items 0
PAT 2 4 3 4 1 3 -3 0 8 10
Minority Interest 0 0 0 0 0 0 0
Share Associate
Other Related Items
Consolidated Net Profit 2 4 3 4 1 3 -3 0 8 10
Adjusted EPS 3 5 3 4 1 4 -3 0 8 9

Parnax Lab Ltd. Cash Flow

View details >>
Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 6 0 0 3 16 13 9 9 6 9
Cash Fr. Inv. -1 -6 -4 -6 -10 -5 -11 -13 -7 -17
Cash Fr. Finan. -3 6 6 1 -5 -7 1 5 0 12
Net Change 1 0 1 -2 0 1 -1 0 0 4
Cash & Cash Eqvt 1 1 2 0 0 1 0 0 0 4

Parnax Lab Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 62.59 62.59 62.59 67.58 67.58 72.30 72.30 72.30 72.30
Public 37.41 37.41 37.41 32.42 32.42 27.70 27.70 27.70 27.70
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 14.68 14.68 14.68 11.78 11.78 9.41 9.41 9.41 9.41

Parnax Lab Ltd. Announcements

View details >>
Fri, 29 Sep 2023
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 41st Annual General Meeting held on 29th September 2023
Fri, 29 Sep 2023
Closure of Trading Window
Closure of Trading Window w.e.f. 1st October 2023 and shall open 48 hours after the Unaudited Financial Results for the Quarter and Half Year Ended 30th September 2023 become generally available to the public.
Fri, 29 Sep 2023
Announcement under Regulation 30 (LODR)-Change in Directorate
Appointment of Mr. Harish S. Panpalia as a Independent Director w.e.f. 11th August 2023

Parnax Lab Ltd. Technical Scans

View details >>
Tue, 03 Oct 2023
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Opening at High Opening at High
Opening at Low Opening at Low
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months

Parnax Lab Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 273,992.06 1,121.75 -1.8%
Divi's Laboratories Ltd. 98,792.80 3,702.05 -0.5%
Cipla Ltd. 95,478.34 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. 91,061.15 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. 73,583.24 5,048.70 -1.4%
Mankind Pharma Ltd. 72,079.88 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. 63,636.20 1,865.70 -0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 32.48 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-06 66.87 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-06 30.69 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.28 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 110.06 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 56.25 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 50.53 1,865.70 -0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.72 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-06 7.53 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-06 3.92 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.71 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.73 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 5.89 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.68 1,865.70 -0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 0.02 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,865.70 -0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 12.85 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,865.70 -0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 12.85 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,865.70 -0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,865.70 -0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,865.70 -0.8%

Parnax Lab Ltd. FAQ's

What is Parnax Lab share price?
Can I buy Parnax Lab shares now?
What is the Market Cap of Parnax Lab?
What are the key metrics to analyse Parnax Lab?
What is the 52 Week High and Low of Parnax Lab?
What is the trend of Parnax Lab share price?